Moderna’s anti-Covid vaccination was authorised by the European Union’s medicines authority on Thursday for children aged six to eleven, making it the second vaccine to be licenced for younger children in the 27-member bloc.
“The EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the Covid-19 vaccine Spikevax to include use in children aged 6 to 11,” the Amsterdam-based European Medicines Agency said in a statement.
The jab, developed by US-based pharmaceutical company Moderna, has already been approved for adults and children aged 12 and above.
“As in the older age group, the vaccine is given as two injections in the muscles of the upper arm, four weeks apart,” the EMA said.
Pfizer/BioNTech’s anti-Covid shot called Comirnaty was greenlit for children aged five to 11 in November.
The regulator has so far approved five vaccines for use in the EU: Pfizer and Moderna, which use messenger RNA technology, AstraZeneca and Johnson & Johnson, which use viral vector technology, and Novavax, which is based on a spike protein produced in a laboratory.
In recent years, diet and lifestyle have been recognized as crucial factors influencing cancer risk.…
Surgical advancements have evolved significantly over the decades, leading to improved precision, reduced recovery time,…
A tragic incident in northwest Delhi has sparked a medical negligence controversy after a 20-year-old…
Maharashtra is set to witness a significant transformation in its public health sector with the…
Sleep is essential for overall health, yet many people suffer from sleep disorders that disrupt…
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…